HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N-retinoylproline

has antineoplastic activity; structure in first source

Also Known As:

N-all-trans-retinoyl-L-proline

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Wu, Xing Zhong: 2 articles (07/2009 - 08/2006)
2.	Bao, Wei Qi: 1 article (07/2009)
3.	Guo, Lin: 1 article (07/2009)
4.	Sheng, Wei Qi: 1 article (07/2009)
5.	Wu, Li Hui: 1 article (07/2009)
6.	Zhang, Huan Le: 1 article (07/2009)
7.	Zheng, Jing: 1 article (07/2009)
8.	Chen, Yi: 1 article (08/2006)
9.	Ding, Sheng-Song: 1 article (08/2006)
10.	Hu, Ping: 1 article (08/2006)

Related Diseases

1.	Stomach Neoplasms (Stomach Cancer) 07/01/2009 - "After treatment with 5-FU (5-fluorouracil) and ATRP (N-all-trans-retinoyl-L-proline), the expression of 3'-sulfo-Le(a) antigen was markedly down regulated in SCG7901 gastric cancer cells. "
2.	Neoplasm Metastasis (Metastasis) 08/01/2006 - "A new compound, N-all-trans-retinoyl-L-proline (ATRP), has been developed and its metastasis inhibition activity has been studied. "
3.	Hepatocellular Carcinoma (Hepatoma) 08/01/2006 - "N-all-trans-retinoyl-L-proline inhibits metastatic potential of hepatocellular carcinoma cells."

Related Drugs and Biologics

1.	Fluorouracil (Carac)
2.	Antigens

Related Therapies and Procedures

1.	Aftercare (After-Treatment)